Back to Trades
Total Value
$471.0K
Filing Date
Jun 18, 2026
1 transactions
Trade Summary
On Jun 17, 2026, THEUER CHARLES, Insider, reported $471.0K of 4D Molecular Therapeutics, Inc. (FDMT) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $9.42. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- 4D Molecular Therapeutics, Inc.
- Ticker Symbol
- FDMT
- CIK
- 0001650648
Insider Information
- Name
- THEUER CHARLES
- Role
- Insider
- Location
- EMERYVILLE, CA
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 17, 2026
- Accession Number
- 0001193125-26-276166
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | FDMT derivative | 50,000 | $9.42 | Grant/Award | $471.0K |
Want live alerts when THEUER CHARLES trades again?
Download Insider Trades to track FDMT, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Automatically granted pursuant to the terms of the Company's non-employee director compensation program.
- (F2)The stock option vests and becomes exercisable with respect to 1/3 of the total shares on June 17, 2027 and in equal monthly installments thereafter, subject to the Reporting Person continuing service to Issuer through each vesting date, until the shares are fully vested on June 17, 2029. Additionally, the stock options will vest in full upon the consummation of a Change in Control (as defined in the 2020 Incentive Award Plan).